← Back to catalogue

InflammaDry

FDA UDI

Class I (US FDA UDI)

by Quidel Corp.

Identity

Trade Name
InflammaDry FDA UDI
Generic Name
Matrix metalloproteinase-9 (MMP-9) IVD, kit, rapid ICT, clinical FDA UDI
Device Name
InflammaDry FDA UDI
Model / Reference
RPS-ID-20 FDA UDI
Description
InflammaDry FDA UDI

Identifiers

Catalog Number
RPS-ID-20 FDA UDI
Primary DI / UDI-DI
30014613336747 FDA UDI
510(k) Number
K132066 FDA UDI
FDA Product Code
PFQ FDA UDI
JJX FDA UDI
GMDN Term
Matrix metalloproteinase-9 (MMP-9) IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1540 FDA UDI
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Matrix metalloproteinase-9 (MMP-9) IVD, kit, rapid ICT, clinical

InflammaDry by Quidel Corp. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Matrix metalloproteinase-9 (MMP-9) IVD, kit, rapid ICT, clinical.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Quidel Corp.

Sources (1)

  • FDA UDI b0e61b13-929c-4eef-8237-9731fc3eb3ab 36 fields · synced Jun 1, 2026